Segments of Business and Geographic Areas (Tables)

6 Months Ended

Jun. 29, 2014



	Fiscal Second Quarters Ended
(Dollars in Millions)	June 29, 2014		June 30, 2013	Percent Change

Consumer
United States	$	1,320	1,326	(0.5	)%
International	2,424		2,332	3.9
Total	3,744		3,658	2.4
Pharmaceutical
United States	4,613		3,377	36.6
International	3,896		3,648	6.8
Total	8,509		7,025	21.1
Medical Devices & Diagnostics
United States	3,199		3,243	(1.4	)
International	4,043		3,951	2.3
Total	7,242		7,194	0.7
Worldwide
United States	9,132		7,946	14.9
International	10,363		9,931	4.4
Total	$	19,495	17,877	9.1	%




	Fiscal Six Months Ended
(Dollars in Millions)	June 29, 2014		June 30, 2013	Percent Change

Consumer
United States	$	2,629	2,674	(1.7	)%
International	4,672		4,659	0.3
Total	7,301		7,333	(0.4	)
Pharmaceutical
United States	8,353		6,848	22.0
International	7,654		6,945	10.2
Total	16,007		13,793	16.1
Medical Devices & Diagnostics
United States	6,354		6,449	(1.5	)
International	7,948		7,807	1.8
Total	14,302		14,256	0.3
Worldwide
United States	17,336		15,971	8.5
International	20,274		19,411	4.4
Total	$	37,610	35,382	6.3	%

Operating profit by segment of business



	Fiscal Second Quarters Ended
(Dollars in Millions)	June 29, 2014		June 30, 2013	Percent Change
Consumer⁽¹⁾	$	703	511	37.6	%
Pharmaceutical ⁽²⁾	3,469		2,992	15.9
Medical Devices & Diagnostics⁽³⁾	1,703		1,517	12.3
Segments operating profit	5,875		5,020	17.0
Less: Expense not allocated to segments⁽⁴⁾	249		227
Worldwide income before taxes	$	5,626	4,793	17.4	%




	Fiscal Six Months Ended
(Dollars in Millions)	June 29, 2014		June 30, 2013	Percent Change
Consumer ⁽¹⁾	$	1,181	1,058	11.6	%
Pharmaceutical ⁽²⁾	6,674		5,409	23.4
Medical Devices & Diagnostics⁽³⁾	3,670		3,035	20.9
Segments operating profit	11,525		9,502	21.3
Less: Expense not allocated to segments⁽⁴⁾	475		448
Worldwide income before taxes	$	11,050	9,054	22.0	%

(1) Includes a gain of $332 million from the divestiture of the K-Y^® brand recorded in the fiscal second quarter and first fiscal six months of 2014. Includes a gain on the sale of intangible and other assets of $55 million recorded in the first fiscal six months of 2013.

(2) Includes litigation expense of $178 million recorded in the first fiscal six months of 2013 and a net gain of $420 million on equity investment transactions, primarily the sale of Elan American Depositary Shares, in the fiscal second quarter and first fiscal six months of 2013.

(3) Includes Synthes integration/transaction costs of $144 million, litigation expense of $276 million and an in-process research and development charge of $4 million recorded in the fiscal second quarter of 2014. Includes Synthes integration/transaction costs of $122 million, litigation expense of $375 million and $69 million for costs associated with the ASR^TM Hip program recorded in the fiscal second quarter of 2013.

Includes Synthes integration/transaction costs of $262 million, litigation expense of $276 million and an in-process research and development charge of $22 million recorded in the first fiscal six months of 2014. Includes Synthes integration/transaction costs of $380 million, litigation expense of $720 million, an in-process research and development charge of $64 million and $82 million for costs associated with the ASR^TM Hip program recorded in the first fiscal six months of 2013.

(4) Amounts not allocated to segments include interest income/expense, noncontrolling interests and general corporate income/expense. The first fiscal six months of 2013 includes litigation expense of $6 million.

Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas



	Fiscal Second Quarters Ended
(Dollars in Millions)	June 29, 2014		June 30, 2013	Percent Change
United States	$	9,132	7,946	14.9	%
Europe	5,056		4,672	8.2
Western Hemisphere, excluding U.S.	1,863		1,905	(2.2	)
Asia-Pacific, Africa	3,444		3,354	2.7
Total	$	19,495	17,877	9.1	%




	Fiscal Six Months Ended
(Dollars in Millions)	June 29, 2014		June 30, 2013	Percent Change
United States	$	17,336	15,971	8.5	%
Europe	9,941		9,153	8.6
Western Hemisphere, excluding U.S.	3,558		3,688	(3.5	)
Asia-Pacific, Africa	6,775		6,570	3.1
Total	$	37,610	35,382	6.3	%

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details